Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort.,The Journal of Urology

当前位置： X-MOL 学术 › J. Urol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort.
The Journal of Urology ( IF 5.9 ) Pub Date : 2021-08-16 , DOI: 10.1097/ju.0000000000001937
Lauren Folgosa Cooley ₁ , Adaeze A Emeka ₁ , Travis J Meyers ₂ , Phillip R Cooper ₁ , Daniel W Lin _{3,

4} , Antonio Finelli ₅ , James A Eastham ₆ , Christopher J Logothetis ₇ , Leonard S Marks ₈ , Danny Vesprini ₉ , S Larry Goldenberg ₁₀ , Celestia S Higano ₁₀ , Christian P Pavlovich ₁₁ , June M Chan _{2,

12} , Todd M Morgan ₁₃ , Eric A Klein ₁₄ , Daniel A Barocas ₁₅ , Stacy Loeb ₁₆ , Brian T Helfand ₁₇ , Denise M Scholtens ₁₈ , John S Witte _{2,

12,

19} , William J Catalona ₁ ,

Affiliation

Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.
Fred Hutchinson Cancer Research Center, Cancer Prevention Program, Public Health Sciences, Seattle, Washington.
Department of Urology, University of Washington, Seattle, Washington.
Division of Urology, Department of Surgery, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Departments of Genitourinary Medical Oncology and Urology, the University of Texas M. D. Anderson Cancer Center, Houston, Texas.
Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Odette Cancer Centre, Sunnybrook Health and Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
The Brady Urological Institute, the Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Urology, University of California, San Francisco, San Francisco, California.
Department of Urology, University of Michigan, Ann Arbor, Michigan.
Glickman Urological and Kidney Institute, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio.
Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Departments of Urology and Population Health, New York University Langone Health and Manhattan Veterans Affairs Medical Center, New York, New York.
Division of Urology, NorthShore University Health System, Evanston, Illinois.
Division of Biostatistics, Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.

We examined the demographic and clinicopathological parameters associated with the time to convert from active surveillance to treatment among men with prostate cancer.

中文翻译：